课题基金 / 基金详情

Novel pharmacological strategies to treat cognitive dysfunction in COPD

Novel pharmacological strategies to treat cognitive dysfunction in COPD
治疗慢性阻塞性肺病认知功能障碍的新药理学策略
批准号:
nhmrc : 1139843
负责人:
A/Pr Sarah Spencer
金额:
$58.99万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2020-12-31

项目摘要

项目成果

A/Pr Sarah Spencer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic Obstructive Pulmonary Disease (COPD) is a major incurable global health burden and is the 4th largest cause of death worldwide. Up to 60% of COPD patients suffer from cognitive dysfunction (i.e. a brain disorder which affects learning, memory, attention) which often leads to dementia. The reason for this is unknown so the aim of this study is to determine why people with COPD suffer from mental disorders then develop novel treatments to treat these disorders in COPD patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel pharmacological strategies to treat cognitive dysfunction in COPD
  • 批准号:
    nhmrc : GNT1139843
  • 项目类别:
    Project Grants
  • 资助金额:
    $87.25万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Sarah Spencer
  • 依托单位:
Targeting central inflammation to combat obesity and obesity-related cognitive dysfunction
  • 批准号:
    nhmrc : 1128646
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $32.12万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Sarah Spencer
  • 依托单位:
Targeting central inflammation to combat obesity and obesity-related cognitive dysfunction
  • 批准号:
    nhmrc : GNT1128646
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $47.01万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Sarah Spencer
  • 依托单位:
Investigating a novel agent to limit brain injury and post-stroke complications
  • 批准号:
    nhmrc : 1068442
  • 项目类别:
    Project Grants
  • 资助金额:
    $27.5万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Sarah Spencer
  • 依托单位:
海外基金